Literature DB >> 23129083

Health-related quality of life in children and adolescents with Duchenne muscular dystrophy.

Karen Uzark1, Eileen King, Linda Cripe, Robert Spicer, Jackie Sage, Kathleen Kinnett, Brenda Wong, Jesse Pratt, James W Varni.   

Abstract

OBJECTIVES: The purpose of this study was to assess health-related quality of life (QoL) in children with Duchenne muscular dystrophy (DMD), including development and field-testing of a DMD-specific module integrated with the core Pediatric Quality of Life Inventory (PedsQL).
METHODS: The PedsQL 4.0 Generic Core and DMD Module Scales were completed by 203 families, including 200 parents and 117 boys with DMD. Scores on the PedsQL Core Scales were compared with those of matched healthy children. Relationships between PedsQL scores and patient characteristics were examined.
RESULTS: By both parent report and child self-report, mean PedsQL scores for boys with DMD were significantly lower than those for healthy children for physical and psychosocial QoL (P < .0001), with significantly impaired psychosocial QoL scores self-reported by 57%. Psychosocial QoL, by self-report only, tended to be higher in the older boys (13-18 years) than in younger boys (8-12 years; P = .05) and was not significantly associated with use of mobility aids. Although parents reported higher Daily Activities scores in boys receiving steroids (P = .01), boys receiving steroids reported no difference in Daily Activities but significantly less worry (P = .004). Parent-child concordance was generally in the fair to poor range. Internal consistency reliability coefficients for PedsQL DMD module scales ranged from 0.66 to 0.86.
CONCLUSIONS: Overall, boys with DMD reported significantly lower QoL than their healthy peers. Despite decreased physical functioning, older boys seem to perceive better psychosocial QoL than perceived by their parents and by younger boys, unrelated to their need for mobility aids.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23129083     DOI: 10.1542/peds.2012-0858

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  34 in total

Review 1.  Quality improvement in neurology: muscular dystrophy quality measures.

Authors:  Pushpa Narayanaswami; Richard Dubinsky; David Wang; Gina Gjorvad; William David; Jonathan Finder; Benn Smith; Jianguo Cheng; Frederic Shapiro; Michelle Mellion; Christopher Spurney; Jodi Wolff; John England
Journal:  Neurology       Date:  2015-09-08       Impact factor: 9.910

2.  Measuring quality of life in muscular dystrophy.

Authors:  Carla M Bann; Richard T Abresch; Barbara Biesecker; Kristin Caspers Conway; Chad Heatwole; Holly Peay; Peter Scal; Jonathan Strober; Karen Uzark; Jodi Wolff; Marjorie Margolis; Angela Blackwell; Natalie Street; Angela Montesanti; Julie Bolen
Journal:  Neurology       Date:  2015-02-06       Impact factor: 9.910

3.  Caregiver-Reported Quality of Life in Youth with Down Syndrome.

Authors:  Melissa S Xanthopoulos; Rachel Walega; Rui Xiao; Divya Prasad; Mary M Pipan; Babette S Zemel; Robert I Berkowitz; Sheela N Magge; Andrea Kelly
Journal:  J Pediatr       Date:  2017-07-24       Impact factor: 4.406

4.  Can in-the-moment diary methods measure health-related quality of life in Duchenne muscular dystrophy?

Authors:  Paula Bray; Anita C Bundy; Monique M Ryan; Kathryn N North
Journal:  Qual Life Res       Date:  2016-11-03       Impact factor: 4.147

5.  Predictors of Health-Related Quality of Life in boys with Duchenne muscular dystrophy from six European countries.

Authors:  Christiane Otto; Birgit F Steffensen; Ann-Lisbeth Højberg; Claus Barkmann; Jes Rahbek; Ulrike Ravens-Sieberer; Annette Mahoney; Julia Vry; Kathrin Gramsch; Rachel Thompson; Sunil Rodger; Kate Bushby; Hanns Lochmüller; Janbernd Kirschner
Journal:  J Neurol       Date:  2017-02-07       Impact factor: 4.849

6.  Prioritizing Parental Worry Associated with Duchenne Muscular Dystrophy Using Best-Worst Scaling.

Authors:  Holly Landrum Peay; I L Hollin; J F P Bridges
Journal:  J Genet Couns       Date:  2015-08-21       Impact factor: 2.537

Review 7.  Health-related quality of life and symptom reporting: similarities and differences between children and their parents.

Authors:  Christine Eiser; James W Varni
Journal:  Eur J Pediatr       Date:  2013-05-29       Impact factor: 3.183

8.  Cost-Effectiveness of Ventricular Assist Device Destination Therapy for Advanced Heart Failure in Duchenne Muscular Dystrophy.

Authors:  Defne A Magnetta; JaHyun Kang; Peter D Wearden; Kenneth J Smith; Brian Feingold
Journal:  Pediatr Cardiol       Date:  2018-05-17       Impact factor: 1.655

Review 9.  Measuring quality of life in children with spinal muscular atrophy: a systematic literature review.

Authors:  Shalvaree Vaidya; Stefan Boes
Journal:  Qual Life Res       Date:  2018-07-24       Impact factor: 4.147

10.  Longitudinal changes in clinical outcome measures in COL6-related dystrophies and LAMA2-related dystrophies.

Authors:  Minal S Jain; Katherine Meilleur; Eunhee Kim; Gina Norato; Melissa Waite; Leslie Nelson; Michelle McGuire; Tina Duong; Katherine Keller; Donovan J Lott; Allan Glanzman; Kristy Rose; Marion Main; Courtney Fiorini; Irene Chrismer; Melody Linton; Monal Punjabi; Jeffrey Elliott; Fatoumata Tounkara; Ruhi Vasavada; Ranjani Logaraj; Jocelyn Winkert; Sandra Donkervoort; Meganne Leach; Jahannaz Dastgir; Linda Hynan; Carmel Nichols; Elizabeth Hartnett; Gilberto M Averion; James C Collins; Eunice S Kim; Angela Kokkinis; Alice Schindler; Kristen Zukosky; Robert Fee; Veronica Hinton; Payam Mohassel; Diana Bharucha-Goebel; Carole Vuillerot; Peter McGraw; Mark Barton; Joseph Fontana; Anne Rutkowski; A Reghan Foley; Carsten G Bönnemann
Journal:  Neurology       Date:  2019-10-25       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.